Pyrido(3,2-d)pyrimidine derivatives represented by the structural formula (Ia): wherein, R
1
, R
2
and R
3
are defined herein, pharmaceutical acceptable addition salts, stereochemical isomeric forms, N-oxides, solvates and pro-drugs thereof, for use in the treatment of hepatitis C.
该文描述了结构式(Ia)所代表的
吡啶并[3,2-d]
嘧啶衍
生物:其中,R1、R2和R3在此定义,以及其药物可接受的加合盐、立体
化学异构体形式、N-
氧化物、溶剂化合物和前药,用于治疗丙型肝炎。